Diabetes, Cardiovascular Risks, and Lipoproteins

112 та иш

1. Influence of abnormal lipid components in statin-naive young adults: Is there any gap?

   Jamol Uzokov

   БошқаLipoproteins and Cardiovascular HealthEuropean Journal of Preventive Cardiology20197 иқтибос

   ABIABI:AkademIndex/openalex/2019.other.000001

2. GW28-e0699 Cardiovascular risk stratification and gender differences in hypertensive patients with metabolic syndrome

   Alyavi Anis Lutfullayevich, Alyavi Baxrom Anisxonovich, Uzokov Jamol Kamilovich +2

   МақолаDiabetes, Cardiovascular Risks, and LipoproteinsJournal of the American College of Cardiology20174 иқтибос

   ABIABI:AkademIndex/openalex/2017.article.000213

3. Influence of diet with low glycemic index on triglycerides, glycated hemoglobin and LDL-C/HDL-C ratio in patients with coronary artery disease

   Jamol Uzokov, Bakhromkhon Alyavi, Djamshid Payziev

   МақолаLiver Disease Diagnosis and TreatmentAtherosclerosis20202 иқтибос

   ABIABI:AkademIndex/openalex/2020.article.000731

4. Assessing the Effectiveness of Type 2 Diabetes Screening in the Republic of Uzbekistan

   Anna Alieva, Anvar Alimov, Feruza Khaidarova +5

   МақолаDiabetes, Cardiovascular Risks, and LipoproteinsInternational Journal of Endocrinology and Metabolism20222 иқтибос

   ABIABI:AkademIndex/openalex/2022.article.000789

5. Global burden of metabolic diseases, 1990–2021

   Huai Zhang, Xiaodong Zhou, Michael D. Shapiro +53

   МақолаDiabetes, Cardiovascular Risks, and LipoproteinsMetabolism20242 иқтибос

   ABIABI:AkademIndex/openalex/2024.article.000002

6. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

   Antonio J. Vallejo‐Vaz, Martina De Marco, Christophe Stevens +82

   МақолаLipoproteins and Cardiovascular HealthAtherosclerosis20181 иқтибос

   ABIABI:AkademIndex/openalex/2018.article.000004

7. INFLUENCE OF METABOLIC SYNDROME ON RENAL FUNCTION IN PATIENTS WITH HYPERTENSION

   Jamol Uzokov, Bakhromkhon Alyavi, Shukhratjon Azizov +1

   МақолаBlood Pressure and Hypertension StudiesJournal of Hypertension20181 иқтибос

   ABIABI:AkademIndex/openalex/2018.article.000513

8. Prognostic value of metabolic syndrome for the development of type 2 diabetes mellitus and cardiovascular disease

   A. L. Alyavi, Bakhromkhon Alyavi, Jamol Uzokov

   МақолаDiabetes, Cardiovascular Risks, and LipoproteinsAtherosclerosis20201 иқтибос

   ABIABI:AkademIndex/openalex/2020.article.001193

9. Burden of Ischemic Heart Disease in Central Asian Countries, 1990–2017

   Michelle Lui, Saeid Safiri, Alibek Mereke +10

   МақолаAcute Myocardial Infarction ResearchIJC Heart & Vasculature20211 иқтибос

   ABIABI:AkademIndex/openalex/2021.article.000229

10. Features of the Trajectories of Glycated Hemoglobin in Patients with CHD and DM 2

    Раиса Тригулова, Sh.Sh. Mukhtarova, Dilnoza Alimova +2

    МақолаNeurological Disorders and TreatmentsAmerican Heart Journal20231 иқтибос

    ABIABI:AkademIndex/openalex/2023.article.003329

11. DIAGNOSTICS AND TREATMENT OF CHRONIC CEREBRAL CIRCULATORY DISORDERS AGAINST THE BACKGROUND OF DIABETES MELLITUS

    Dzhurabekova Aziza Takhirovna, Shaymatov Rakhmonberdi Uktamovich

    МақолаDiabetes Management and ResearchThe American Journal of Medical Sciences and Pharmaceutical Research20231 иқтибос

    ABIABI:AkademIndex/openalex/2023.article.003785

12. Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021

    Xiaodong Zhou, Qin‐Fen Chen, Wah Yang +48

    МақолаDiabetes, Cardiovascular Risks, and LipoproteinsEClinicalMedicine20241 иқтибос

    ABIABI:AkademIndex/openalex/2024.article.000004

13. Prediction of glycosylated hemoglobin level in patients with cardiovascular diseases and type 2 diabetes mellitus with respect to anti-diabetic medication

    Alisher Ikramov, Shakhnoza Mukhtarova, Раиса Тригулова +2

    МақолаDiabetes Treatment and ManagementFrontiers in Endocrinology20241 иқтибос

    ABIABI:AkademIndex/openalex/2024.article.001247

14. Thrombolysis use in STEMI patients in Central Asia: lessons from the Bukhara region of Uzbekistan

    Dildora Aslonova, Rakhmon Amanov, Vokhid Zokirov +5

    МақолаAcute Myocardial Infarction ResearchFrontiers in Health Services20261 иқтибос

    ABIABI:AkademIndex/openalex/2026.article.000440

15. Influence of variability in risk factors on cardiovascular disease outcomes in type 2 diabetes mellitus

    Jamol Uzokov

    БошқаDiabetes, Cardiovascular Risks, and LipoproteinsEuropean Journal of Preventive Cardiology20231 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.586760

16. QANDLI DIABET KASALLIGI FONIDA YURAK QON TOMIR TIZIMI KASALLIKLARINING KLINIK KECHUV XUSUSIYATLARI

    Исламова Камола Акрамовна, Карабаева Гульчехра Худойбердиевна

    МақолаDiabetes, Cardiovascular Risks, and Lipoproteins20201 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.721580

17. Comparison of simvastatin and guar gum in the treatment hyperlipidemic patients with diabetes mellitus II type

    K.M. Yafasov, G. Shamukhitdinova

    МақолаDiabetes, Cardiovascular Risks, and LipoproteinsAtherosclerosis20000 иқтибос

    ABIABI:AkademIndex/openalex/2000.article.000271

18. Patterns of adult tobacco use in Uzbekistan

    Gulnoza Usmanova, Yehuda Neumark, Mario Baras +1

    МақолаSmoking Behavior and CessationEuropean Journal of Public Health20110 иқтибос

    ABIABI:AkademIndex/openalex/2011.article.000153

19. Prooxidative Role of Hyperinsulinemia in Metabolic Sydrome Formation

    Nelli Uzbekova, Dilorom Abdullaevna Musakhodjaeva

    МақолаAdipose Tissue and MetabolismInternational Journal of Public Health Science (IJPHS)20140 иқтибос

    ABIABI:AkademIndex/openalex/2014.article.000443

20. Cardiometabolic disease risk and HIV status in rural South Africa: establishing a baseline

    Samuel J. Clark, F. Xavier Gómez‐Olivé, Brian Houle +7

    МақолаHIV-related health complications and treatmentsBMC Public Health20150 иқтибос

    ABIABI:AkademIndex/openalex/2015.article.000019

21. Blood lipid parameters in patients with Parkinson's disease

    Elvina Giyazitdinova, Bakhrom Muinjonov, Gulnora Rakhimbayeva +1

    МақолаDiabetes, Cardiovascular Risks, and LipoproteinsParkinsonism & Related Disorders20150 иқтибос

    ABIABI:AkademIndex/openalex/2015.article.000558

22. Alpha-Adducin Gly460Trp Polymorphism and Clinical Efficacy of Indapamide in Uzbek Hypertensive Patients

    Guzal Abdullaeva, Tashkent, Uzbekistan, Gulnoz Khamidullaeva

    МақолаBlood Pressure and Hypertension StudiesInternational Journal of Biomedicine20150 иқтибос

    ABIABI:AkademIndex/openalex/2015.article.000903

23. Multifactor Assessment of Metabolic Syndrome Risk in Uzbek Children and Adolescents with Obesity

    Gulnara Rakhimova, Tashkent, Republic of Uzbekistan, Shakhnoza Azimova

    МақолаDiabetes, Cardiovascular Risks, and LipoproteinsInternational Journal of Biomedicine20160 иқтибос

    ABIABI:AkademIndex/openalex/2016.article.000565

24. Changes in plasma lipoprotein subfractions in patients with polygenic hypercholesterolemia, familial combined hyperlipoproteinemia, and familial hypercholesterolemia after atorvastatin

    Bakhrom Muinjonov, Elvina Giyazitdinova

    МақолаLipoproteins and Cardiovascular HealthAtherosclerosis20160 иқтибос

    ABIABI:AkademIndex/openalex/2016.article.000722

25. Epidemiological data of type 1 diabetes mellitus in children in Uzbekistan, 1998-2014

    Gulnara Rakhimova, Nasiba Alimova, Alexsandr Ryaboshtan +3

    МақолаDiabetes and associated disordersPediatric Diabetes20170 иқтибос

    ABIABI:AkademIndex/openalex/2017.article.000186